10-KPeriod: FY2008

EIDP, Inc. Annual Report, Year Ended Dec 31, 2008

Filed February 12, 2009For Securities:CTA-PBCTA-PA

Summary

E. I. du Pont de Nemours and Company (DuPont) reported significant challenges in 2008, impacted by a global economic recession and rising raw material and energy costs. Net sales increased by 4% to $30.5 billion, driven by price increases and growth in emerging markets, but were offset by a 5% volume decline, particularly in the fourth quarter. Net income saw a substantial decrease of 33% to $2.0 billion, or $2.20 per diluted share, largely due to the economic downturn and a $535 million restructuring charge. The company initiated cost-saving measures, including workforce reductions and spending cuts, to align with lower demand and improve future competitiveness, targeting significant cost and working capital reductions for 2009. Despite the challenging environment, DuPont highlighted continued investment in research and development and strategic growth areas like agriculture and biosciences. The Agriculture & Nutrition segment performed strongly with a 16% sales increase and a 22% rise in pre-tax operating income. However, segments like Coatings & Color Technologies and Performance Materials experienced significant declines in profitability due to decreased demand in automotive and construction sectors, exacerbated by restructuring charges. The company maintained its long history of dividend payments and affirmed its financial discipline, aiming to manage liquidity through operations, credit lines, and cash management strategies, despite negative outlooks from rating agencies.

Financial Statements
Beta
Revenue$30.53B
R&D Expenses$1.39B
SG&A Expenses$3.59B
Operating Expenses$29.45B
Interest Expense$376.00M
Net Income$2.01B
EPS (Basic)$2.21
EPS (Diluted)$2.20
Shares Outstanding (Basic)902.41M
Shares Outstanding (Diluted)907.37M

Key Highlights

  • 1Net sales increased 4% to $30.5 billion in 2008, but full-year sales volume declined 5% due to the economic recession, particularly in Q4.
  • 2Net income decreased significantly by 33% to $2.0 billion, or $2.20 per diluted share, impacted by lower sales volumes and a $535 million restructuring charge.
  • 3The company announced a global restructuring program in Q4 2008, including approximately 2,500 job reductions, aimed at achieving $130 million in savings for 2009 and $250 million annually thereafter.
  • 4The Agriculture & Nutrition segment was a strong performer, with sales up 16% and pre-tax operating income up 22%, driven by strong seed and crop protection product sales.
  • 5Segments like Coatings & Color Technologies and Performance Materials faced significant headwinds, with lower demand in automotive and construction markets leading to reduced profitability.
  • 6DuPont continued to invest in research and development, with R&D expenses increasing to $1.4 billion.
  • 7The company's balance sheet remained substantial, with total assets of $36.2 billion, though debt levels increased by $2.4 billion to $9.7 billion.

Frequently Asked Questions

In 2008, DuPont reported a net sales increase of 4% to $30.5 billion, primarily driven by higher selling prices and favorable currency exchange. However, sales volume decreased by 5%, with a pronounced decline in the fourth quarter due to the global economic recession. Net income fell 33% to $2.0 billion, or $2.20 per diluted share, largely impacted by lower volumes, higher raw material costs, and significant restructuring charges.

The primary factors impacting DuPont's profitability were the global economic recession, which led to decreased demand, particularly in the automotive and construction sectors, and increased raw material and energy costs. A significant $535 million restructuring charge recorded in the fourth quarter also negatively impacted net income. The company implemented cost-reduction measures and workforce reductions to mitigate these impacts.

The Agriculture & Nutrition segment was a strong performer, with sales up 16% and profitability up 22%. Conversely, the Coatings & Color Technologies and Performance Materials segments experienced significant declines in pre-tax operating income due to weak demand in their key end markets and restructuring charges. The Electronic & Communication Technologies segment saw a decrease in profitability due to higher costs and lower volumes, while the Safety & Protection segment faced similar challenges from reduced demand and increased costs. The Pharmaceuticals segment continued to generate substantial income from its existing drug portfolio.

DuPont projected earnings per share for 2009 to be in the range of $2.00 to $2.50, anticipating continued adverse effects from the global economic recession. The company planned significant cost reductions, capital expenditure alignment, and working capital improvements to navigate the challenging economic environment. While the Agriculture & Nutrition segment was expected to continue growing, other segments were anticipated to face limited revenue growth.